INTERNATIONAL PATENT: MINDRANK THERAPEUTICS (SUZHOU) NEW DRUG RESEARCH AND DEVELOPMENT CO., LTD, 德睿智药（苏州）新药研发有限公司 FILES APPLICATION FOR "NOVEL HETEROCYCLIC COMPOUND FOR REGULATING P53 FUNCTION"

Posted On: 2025-02-15

GENEVA, Feb. 15 -- MINDRANK THERAPEUTICS (SUZHOU) NEW DRUG RESEARCH AND DEVELOPMENT CO., LTD (Unit 603, Building B1, BioBAY Phase I, No.218 Xinghu Street, Suzhou Industrial Park, Suzhou, China (Jiangsu) Pilot Free Trade ZoneSuzhou, Jiangsu 215127), 德睿智药（苏州）新药研发有限公司 (中国江苏省苏州市中国（江苏）自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园一期Bl楼603...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: MINDRANK THERAPEUTICS (SUZHOU) NEW DRUG RESEARCH AND DEVELOPMENT CO., LTD, 德睿智药（苏州）新药研发有限公司 FILES APPLICATION FOR "NOVEL HETEROCYCLIC COMPOUND FOR REGULATING P53 FUNCTION"